2023-03-22 17:35:12 ET
- Heron Therapeutics ( NASDAQ: HRTX ) is scheduled to announce Q4 earnings results on Thursday, March 23rd, after market close.
- The consensus EPS Estimate is -$0.36 (+33.3% Y/Y) and the consensus Revenue Estimate is $27.24M (+31.8% Y/Y).
- Over the last 1 year, HRTX has beaten EPS estimates 50% of the time and has beaten revenue estimates 0% of the time.
- Over the last 3 months, EPS estimates have seen 1 upward revision and 0 downward. Revenue estimates have seen 1 upward revision and 0 downward.
For further details see:
Heron Therapeutics Q4 2022 Earnings Preview